EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibitor Trapping in Kinases

Danislav S Spassov iD, Mariyana Atanasova iD, Irini Doytchinova iD

International Journal of Molecular Sciences · 13.03.2024 · 25 (6) · 3249

DOI: 10.3390/ijms25063249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.03.2024. Verfasst von Danislav S Spassov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Drug Design and Bioinformatics Lab, Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Pyrimidines, Piperazines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria, European Union-NextGenerationEU through the National Recovery and Resilience Plan of the Republic of Bulgaria, Science and Education for Smart Growth Operational Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, we identified a novel mechanism of enzyme inhibition in N-myristoyltransferases (NMTs), which we have named ‘inhibitor trapping’. Inhibitor trapping occurs when the protein captures the small molecule within its structural confines, thereby preventing its free dissociation and resulting in a dramatic increase in inhibitor affinity and potency. Here, we demonstrate that inhibitor trapping also occurs in the kinases. Remarkably, the drug imatinib, which has revolutionized targeted cancer therapy, is entrapped in the structure of the Abl kinase. This effect is also observed in p38α kinase, where inhibitor trapping was found to depend on a ‘magic’ methyl group, which stabilizes the protein conformation and increases the affinity of the compound dramatically. Altogether, these results suggest that inhibitor trapping is not exclusive to N-myristoyltransferases, as it also occurs in the kinase family. Inhibitor trapping could enhance the binding affinity of an inhibitor by thousands of times and is as a key mechanism that plays a critical role in determining drug affinity and potency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesPiperazinesBenzamidesImatinib MesylateFusion Proteins, bcr-ablsrc-Family KinasesProtein Kinase Inhibitors

Stichwörter der Autor:innen

AblSrcbinding affinitybinding affinity predictiondrug designdrug potencyimatinibkinasesprotein conformation

Substanzen

PyrimidinesPiperazinesBenzamidesImatinib MesylateFusion Proteins, bcr-ablsrc-Family KinasesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Drug Design and Bioinformatics Lab, Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.

ORCID-Profile: Danislav S Spassov, Mariyana Atanasova, Irini Doytchinova

Förderung

  • the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria
  • European Union-NextGenerationEU through the National Recovery and Resilience Plan of the Republic of Bulgaria
  • Science and Education for Smart Growth Operational Program
  • European Union through the European Structural and Investment Funds

Zitieren

APA

Spassov, D. S., Atanasova, M., & Doytchinova, I. (2024). Inhibitor Trapping in Kinases. International Journal of Molecular Sciences, 25(6), 3249. https://doi.org/10.3390/ijms25063249

Vancouver

Spassov DS, Atanasova M, Doytchinova I. Inhibitor Trapping in Kinases. International Journal of Molecular Sciences. 2024;25(6):3249. doi:10.3390/ijms25063249

BibTeX
@article{Spassov2024,
  author = {Spassov, Danislav S and Atanasova, Mariyana and Doytchinova, Irini},
  title = {Inhibitor Trapping in Kinases},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {6},
  pages = {3249},
  doi = {10.3390/ijms25063249}
}
Kostenlos starten →